Introduction {#Sec1}
============

*Acinetobacter baumannii* belongs to the ESKAPE group of pathogens (*Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, A. baumannii, Pseudomonas aeruginosa*, and *Enterobacter* spp.), regarded as the most important bacterial species in clinical settings^[@CR1]^. Infections due to multidrug-resistant (MDR) *A. baumannii*, especially carbapenem-resistant strains, are a burden on healthcare facilities owing to limited antibiotic options for treatment^[@CR2]^. The MDR *A. baumannii* has been recently ranked as a bacterium that poses the greatest health threat by World Health Organization^[@CR3]^. Currently, colistin is prescribed as the last resort for the treatment of MDR *A. baumannii* infections^[@CR4]^, but colistin resistance in clinical *A. baumannii* isolates has been increasingly reported^[@CR5]--[@CR7]^. Although the current colistin-resistance rates are still relatively low, the emergence of colistin-resistant *A. baumannii* is a serious public health concern as it limits the therapeutic options for patients.

Colistin resistance in *A. baumannii* is known to occur via several mechanisms. One of these is the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) or phosphoethanolamine (pEtN) to the lipid A moiety of lipopolysaccharide (LPS), which results in a decrease in the net negative charge of the bacterial outer membrane^[@CR8]--[@CR10]^. Colistin resistance has been shown to be regulated by the PmrAB two-component regulatory system^[@CR11]^. Moreover, the loss of LPS due to mutations in the genes related to LPS biosynthesis, such as *lpxC*, *lpxA*, or *lpxD*, is also known to be associated with colistin resistance^[@CR12],[@CR13]^.

Recent studies have revealed that colistin-susceptible *A. baumannii* has a unique capacity to develop colistin dependence after exposure to colistin^[@CR14]--[@CR16]^. Colistin-resistant subpopulations were reportedly obtained by culturing colistin-susceptible (but heteroresistant) *A. baumannii* on cation-adjusted Mueller--Hinton (CA-MH) agar plates containing more than 8 mg/L colistin. As expected, many of these colistin-resistant bacteria could grow well on MH agar plates with 10 mg colistin discs. Interestingly, however, some colonies surviving at colistin concentrations above 8 mg/L grew only near the colistin discs. Further, the patients with colistin-dependent strains showed higher 3- and 7-day treatment failure rates as compared with those without colistin-dependent strains^[@CR16]^.

In the present study, we obtained a colistin-resistant subpopulation and colistin-dependent mutant from a colistin-susceptible parental *A. baumannii* strain by population analysis and disc diffusion assay. We found that the colistin-dependent mutants developed colistin resistance by serial passages in the absence of colistin. We performed the genotypic and phenotypic characterization of the colistin-resistant and colistin-dependent *A. baumannii* strains to evaluate the differences in their lipid A structures. Our results show that colistin dependence in *A. baumannii* may be a transient phenotype en route to acquiring resistance to colistin, and would be one of strategies to tolerate colistin until resistance is developed.

Results {#Sec2}
=======

Conversion of colistin dependence into colistin resistance during successive passages in colistin-free medium {#Sec3}
-------------------------------------------------------------------------------------------------------------

We previously obtained colistin-dependent mutants from colistin-susceptible *A. baumannii* parental strains, including H08-391, through population analysis and colistin disc diffusion assay^[@CR16]^. H08-391 strain belonged to ST75 based on Oxford scheme of multilocus sequence typing (MLST). To investigate the stability of colistin dependence in *A. baumannii*, we selected a colistin-dependent mutant, H08-391D, and a colistin-resistant subpopulation, H08-391R (Fig. [1](#Fig1){ref-type="fig"}). Their colistin minimum inhibitory concentrations (MICs) exceeded 64 mg/L. The colistin-dependent mutant H08-391D showed steady growth regardless of colistin concentration (up to 5120 mg/L). The phenomenon that a strain that survives at high antibiotic concentrations do not grow on a medium without antibiotics may be necessary condition of antibiotic dependence phenotype of the strain, but may not be sufficient. The resistant phenotype of the colistin-resistant mutant, H08-391R, was preserved during a number of successive passages in colistin-free medium. However, the colistin-dependent phenotype of H08-391D was completely converted into the resistant phenotype after four serial passages without colistin (Fig. [1](#Fig1){ref-type="fig"}). This colistin-resistant mutant, H08-391D-R, derived from the colistin-dependent mutant, exhibited a high level of resistance to colistin (MIC: 1280 mg/L), unlike that of the resistant mutant, H08-391R, derived from the susceptible wild-type (WT) strain (MIC: 64--128 mg/L). In addition, the colistin-resistant phenotype of H08-391D-R was stable for up to 20 serial passages in the absence of the antibiotic. Such conversion of the colistin-dependent phenotype into the colistin-resistant phenotype during successive passages in colistin-free media was also found in the strains: H06-855D and H09-146D (Fig. [S1](#MOESM1){ref-type="media"} in the supplemental material). Their parental strains H06-855 and H09-146 belonged to ST69 and ST75 in MLST analysis, respectively.Figure 1Colistin disc diffusion assays showing the development of colistin-dependent and -resistant mutants from the colistin-susceptible wild-type (WT) strain, H08-391. From a colistin-susceptible strain, H08-391, a colistin-resistant (H08-391R) and -dependent mutant (H08-391D) were selected *in vitro* using culture media containing 10 mg/L colistin. H08-391D-R was derived from the colistin-dependent mutant, H08-391D, through subsequent passages in the absence of colistin selection pressure, and exhibited the colistin-resistant phenotype.

Amino acid alterations in PmrCAB, LpxA, LpxD, and LpxC {#Sec4}
------------------------------------------------------

To determine whether specific mutations in the genes associated with colistin resistance in *A. baumannii* conferred colistin dependence or resistance, the gene sequences for the *pmrCAB* operon (3575 bp), *lpxC* (903 bp), *lpxA* (789 bp), and *lpxD* (1071 bp) were determined in H08-391 and H06-855 and their derivatives (Table [1](#Tab1){ref-type="table"}).Table 1Amino acid alterations in the PmrCAB, LpxA, LpxC and LpxD of the *A. baumannii* strains.**StrainAmino acid change in** ^**a,b**^ **:PmrCPmrAPmrBLpxALpxCLpxD**CCP domainTryp_Spc domainRes_reg domainUnknown domainHisKA domainUnknown domainUnknown domain341499540546215170184227154215130*A. baumannii* ACICUHisAspAlaArgProGluAlaGlyArg---H08-39125 aa insertion^c^---------------------------H08-391R25 aa insertion**[Tyr]{.ul}**------**[Gln]{.ul}[Lys]{.ul}[Val]{.ul}**---------H08-391D25 aa insertion---------------------**[IS]{.ul}** ***[Aba1]{.ul}*** **[insertion]{.ul}**---H08-391D-R25 aa insertion---**[Glu]{.ul}[Gly]{.ul}[Gln]{.ul}**------**[Lys]{.ul}[IS]{.ul}** ***[Aba1]{.ul}*** **[insertion]{.ul}**---H06-85525 aa insertion---------------------------------H06-855R25 aa insertion------------**[Tyr]{.ul}**------------------H06-855D25 aa insertion---------------------**[Gly insertion]{.ul}**---------H06-855D-R25 aa insertion---------**[Gln]{.ul}**---------**[Gly insertion]{.ul}**---------^a^Amino acid substitutions and insertions in the colistin-resistant or -dependent strains are in boldface and underline. Amino acids shared with *A. baumannii* ACICU are indicated by hyphen (---).^b^The predicted domains are indicated as follows: CCP, complement control protein domain; Tryp_Spc, trypsin-like serine protease domain; Res_reg, response regulator receiver domain; Unknown, unknown domain; and HisKA, histidine kinase (phosphoacceptor) domain.^c^The sequence of the 25-amino acid insertion in PmrC is YQIPENLKKKWCKDGECYDDILIDS.

Compared with the sequences of the reference strain, *A. baumannii* ACICU, 19 nucleotide substitutions, including an insertion of a 75 bp fragment, were found in the *pmrC* in all our strains sequenced. Most of these nucleotide substitutions were synonymous, and amino acid alterations were found in three sites in the trypsin-like serine protease domain of the PmrC C-terminal region: His499Tyr in H08-391R, and Asp540Glu and Ala546Gly in H08-391D-R (Table [1](#Tab1){ref-type="table"}). Thus, all three amino acid alterations were identified in the colistin-resistant mutants. No amino acid substitutions were found in PmrC of the strains in H06-855 lineage. An insertion of 25 amino acids at position 341 of PmrC was found in all strains, including the colistin-susceptible WT strains H08-391 and H06-855, and this insertion has been previously reported in other *A. baumannii* strains, such as *A. baumannii* ATCC 19606^[@CR8]^. This insertion may not affect PmrC, as it does not introduce any premature stop codons to halt protein processing, or a frameshift mutation in the protein. In the PmrAB two-component regulatory system, one substitution (Arg215Gln) in the PmrA of H08-391R, H08-391D-R and H06-855D-R, and two substitutions (Glu184Lys and Ala227Val) and one substitution (Pro170Tyr) were identified in PmrB of H08-391R and H06-855R, respectively. One substitution (Arg215Lys) was found in the H08-391D-R LpxA and an insertion of glycine at position 154 of LpxA was found both in H06-855D and H06-855D-R. The *lpxC* gene of H08-391D and H08-391D-R was disrupted by an insertion sequence, IS*Aba1* (1189 bp), at position 386. IS*Aba1* may interrupt the lipid A biosynthetic function of LpxC, also known as UDP-3-O-acyl-N-acetylglucosamine deacetylase. No amino acid substitutions were found in LpxD. The nucleotide sequences obtained in this study have been submitted to the GenBank database under accession No. MF541731 to MF541778.

Expression of the *pmrCAB*, *lpxAD*, and *lpxC* genes {#Sec5}
-----------------------------------------------------

The *pmrCAB* operon is associated with the addition of pEtN to lipid A. We found that the expression level of *pmrC* was 46.1-fold higher in the colistin-resistant mutant, H08-391R, as compared to that in the colistin-susceptible parental strain, H08-391 (Fig. [2A](#Fig2){ref-type="fig"}). However, the expression levels of *pmrC* in H08-391D and H08-391D-R were not significantly different from those in the WT strain, H08-391. Likewise, the expression levels of *lpxA* and *lpxC*, which are involved in lipid A biosynthesis, were dramatically increased (16.3- and 32.5-fold, respectively) in H08-391R, as compared to those in H08-391 (Fig. [2A](#Fig2){ref-type="fig"}). Moreover, their expression levels in H08-391D and H08-391D-R were similar to those in H08-391. For H06-855 lineage, the expression level of *pmrC* was significantly increased in the colistin-resistant mutant, H06-855R by about 25.7-fold, compared to that in the colistin-susceptible parental strain (Fig. [2B](#Fig2){ref-type="fig"}). *lpxA* and *lpxC* showed no significant differences in their expression between colistin-susceptible WT strain H06-855 and its colistin-resistant or -dependent mutants, although H06-855R showed 4.6-fold higher level of *lpxA* expression than that of H06-855.Figure 2Expression levels of the *pmrC*, *lpxA*, and *lpxC* genes in the strains in *A. baumannii* H08-391 (**A**) and H06-855 (**B**) lineages. The three genes were found to be overexpressed only in the colistin-resistant mutants, H08-391R and/or H06-855R. Error bars represent the standard deviation of three biological repeats, each performed in duplicate. Statistical significance between each strain was determined using Student's unpaired *t*-test. Data were analyzed using GraphPad Prism 5.

Transcriptomic differences in colistin-susceptible strains and their colistin-dependent mutants {#Sec6}
-----------------------------------------------------------------------------------------------

Transcriptomic analysis revealed that 14 genes exhibited more than 10-fold increases in expression in both colistin-dependent strains H08-391D and H06-855D compared with their colistin-susceptible WT strains (Table [2](#Tab2){ref-type="table"}). ACICU_00544-00546 belonging to the same operon, which encodes a ATP-binding cassette (ABC)-type transporter system, showed higher expression levels in colistin-dependent mutants, exhibiting about 11- to 40-fold increases compared with that of colistin-susceptible strains. ACICU_02898 and ACICU_03145 encoding a lytic transglycosylase and a glycosyltransferase, respectively, also showed increased expression in colistin-dependent mutants, ranging from 14- to 37-fold. The expression of ACICU_00053, ACICU_03132 and ACICU_03329 encoding hypothetical proteins of unknown function were dramatically increased about 200- to 1700-fold in both colistin-dependent strains. Expression levels of eight genes among these 14 genes, showing more than 10-fold increased expression in mRNA sequencing, were compared between colistin-resistant and -dependent strains in H08-391 and H06-855 lineages by qRT-PCR. All tested genes showed increased expression levels consistently with mRNA sequencing results in colistin-dependent H08-391D and H06-855D strains and their derivated colistin-resistant strains (H08-391D-R and H06-855D-R) also have preserved increased expression of the genes (Fig. [3](#Fig3){ref-type="fig"}). However, colistin-resistant subpopulations, H08-391R and H06-855R, derived from colistin-susceptible strains, exhibited a low expression of these genes, unlike that of H08-391D-R and H06-855D-R, derived from the colistin-dependent strains (Fig. [3](#Fig3){ref-type="fig"}). These results suggest that highly expressed genes in colistin-dependent mutants may play a role in development of colistin-dependent mutants and up-regulation of these genes might be not directly involved in colistin resistance.Table 2Differentially expressed genes (more than 10-fold) in both colistin-dependent mutants (H08-391D and H06-855D) compared with their colistin-susceptible parental strains (H08-391 and H06-855).**Locus_tagProductOperonRPKM (Reads Per Kilobase per Million)Fold changeH08-391H08-391DH06-855H06-855DH08-391DH06-855DUp-regulated gene**ACICU_00053Hypothetical protein38.66716982.35022.01037062.303**439.1981683.918**ACICU_00065Hypothetical protein82.5291188.33658.2393712.802**14.39963.751**ACICU_00305Hypothetical protein91.9872368.67962.1652004.310**25.75032.242**ACICU_00521Hypothetical protein35.500355.88039.004240.859**10.02510.175**ACICU_00544Outer membrane proteina106.4661193.71268.4661508.850**11.21222.038**ACICU_00545Peptide ABC transporter permeasea98.0251417.03180.8112586.167**14.45632.003**ACICU_00546Membrane-fusion proteina131.4422034.333110.5874372.488**15.47739.539**ACICU_02357Hypothetical protein201.59210904.023190.53813381.578**54.09070.231**ACICU_02358Hypothetical protein123.32311859.916111.91317536.285**96.169156.695**ACICU_02898Soluble lytic transglycosylase fused to ABC-type amino acid-binding protein61.690834.87972.6031454.194**13.53320.029**ACICU_03132Hypothetical protein40.0388532.02743.37017674.980**213.098407.541**ACICU_03139Hypothetical protein15.70913786.08917.67224091.961**877.5841363.257**ACICU_03145Glycosyltransferase9.883190.7346.414236.188**19.29936.822**ACICU_03329Hypothetical protein1422.63632838.0901101.93337325.033**23.08333.872Down-regulated gene**ACICU_00761Trehalose-6-phosphate synthaseb1070.68039.5263772.52275.715−**27.088**−**49.825**ACICU_00762Trehalose-6-phosphataseb132.94211.010528.55314.933−**12.075**−**35.395**ACICU_01198Ferredoxin3971.377100.45412361.136194.354−**39.534**−**63.601**ACICU_01214Hypothetical protein812.75730.2181452.64955.326−**26.896**−**26.256**ACICU_01221Hypothetical protein904.15053.8926833.76041.259−**16.777**−**165.631**ACICU_01257Hypothetical protein5005.489105.0744975.259176.541−**47.638**−**28.182**ACICU_01420Hypothetical protein403.95011.310480.4637.442−**35.717**−**64.557**ACICU_01421Hypothetical protein285.09813.422494.53816.113−**21.241**−**30.691**ACICU_01422Putative 17 kDa surface antigen10458.16489.390103831.995111.001−**116.995**−**935.416**ACICU_01423Hypothetical protein61421.784332.702523433.243451.036−**184.615**−**1160.513**ACICU_01425Hypothetical proteinc1100.80588.3643043.597183.081−**12.458**−**16.624**ACICU_01426Catalasec7499.909348.23519525.670625.399−**21.537**−**31.221**ACICU_01427Dehydrogenase1272.50925.5293654.28842.142−**49.845**−**86.714**ACICU_01429Hypothetical protein1522.70858.51423480.61966.453−**26.023**−**353.342**ACICU_02269Hypothetical protein304.78121.541642.65637.335−**14.149**−**17.213**ACICU_02276Hypothetical protein210.8878.398689.2677.406−**25.112**−**93.063**ACICU_02382Hypothetical protein335.29418.735502.65741.647−**17.896**−**12.069**ACICU_02406Permeased1743.98319.4092894.19697.369−**89.853**−**29.724**ACICU_02407Aspartate aminotransferased3611.41719.0479451.849131.564−**189.605**−**71.842**ACICU_02431Hypothetical protein2448.49156.3708347.258158.810−**43.436**−**52.561**ACICU_02432Glycosyltransferasee687.28021.9951721.15640.976−**31.248**−**42.004**ACICU_02433SAM-dependent methyltransferasee787.88525.0072259.00150.553−**31.507**−**44.686**ACICU_02434LmbE proteine849.27819.0392670.12742.913−**44.608**−**62.222**ACICU_02435Putative acyl-CoA dehydrogenase-related proteine536.64816.1191664.43933.717−**33.293**−**49.365**ACICU_02436Hypothetical protein24595.952178.72492265.310407.187−**137.620**−**226.592**ACICU_02939Hypothetical proteinf955.15930.2153882.269245.332−**31.613**−**15.825**ACICU_02940Hypothetical proteinf1372.55153.6515114.186358.084−**25.583**−**14.282**ACICU_02941Hypothetical proteinf1078.15743.1493849.177267.170−**24.987**−**14.407**ACICU_02942Hypothetical proteinf421.24815.4121449.073102.863−**27.332**−**14.087**ACICU_02943Hypothetical proteinf748.42535.5052819.347206.037−**21.080**−**13.684**ACICU_02944Putative hemagglutinin/hemolysin-like proteing1769.30770.79520053.9281621.403−**24.992**−**12.368**ACICU_02945Hypothetical proteing2334.49289.04824804.5621986.355−**26.216**−**12.487**ACICU_03499Hypothetical protein1418.42872.9614635.150122.217−**19.441**−**37.926** Figure 3Genes showing high expression levels in colistin-dependent and its converted colistin-resistant strains. The expression levels were evaluated by mRNA sequencing. (**A**) H08-391 lineage; (**B**) H06-855 lineage. Error bars represent the standard deviation of three biological repeats, each performed in duplicate.

In this transcriptomic analysis, 33 down-regulated genes (more than 10-fold) in both colistin-dependent mutants were also founded (Table [2](#Tab2){ref-type="table"}). Most of the genes were annotated as hypothetical genes and only 12 genes encode proteins of known function.

Lipid A modifications in the colistin-dependent and -resistant mutants {#Sec7}
----------------------------------------------------------------------

We assessed the structural changes in LPS arising from differences in the lipid A structures between the colistin-resistant and colistin-dependent mutants. We characterized and compared the lipid A from H08-391 and its derivatives using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry (MS). The mass spectrum for lipid A from the colistin-susceptible WT strain, H08-391, showed major peaks at the mass/charge ratios (*m*/*z*) of 1404, 1728, and 1910, corresponding to the tetra-, hexa-, and hepta-acylated lipid A species, respectively (Fig. [4](#Fig4){ref-type="fig"}). The lipid A from the colistin-resistant strain, H08-391R, showed major peaks at *m*/*z* 1728 and 1910, and an additional minor peak at *m*/*z* 2034, corresponding to the addition of one pEtN residue (Δ*m*/*z* = +124) to the hepta-acylated lipid A species. This pEtN-modified lipid A was only seen in the colistin-resistant strain, H08-391R, indicating that this modification was associated with colistin resistance in *A. baumannii*, and not with colistin dependence. Interestingly, all the major peaks, except for the peak at *m*/*z* 1404, completely disappeared in the mass spectrum for lipid A from the colistin-dependent strain, H08-391D. This suggests that the lipid A moiety in the colistin-dependent strain was either completely absent or had structural defects. The mass spectrum for lipid A from H08-391D-R suggests that the lipid A structure in this strain might be similar to that of its parental colistin-dependent strain, H08-391D. Although H08-391D-R was stable and exhibited higher colistin resistance compared to H08-391R, its lipid A structure differed completely from that of H08-391R, and was probably defective, like that of H08-391D.Figure 4Negative-ion mode matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass spectrometry spectra of the lipid A moieties of lipopolysaccharide isolated from the four strains: H08-391, H08-391R, H08-391D, and H08-391D-R.

LPS deficiency in colistin-dependent *A. baumannii* H08-391D {#Sec8}
------------------------------------------------------------

To assess the ability to produce LPS of colistin-dependent H08-391D with inactivated LpxC, we analyzed the purified LPS from each strain in the H08-391 lineage. To exclude the possibility a loss of LPS during the purification process, we also analyzed the whole cell lysates of each stain. All strains showed similar pattern in whole cell lysate but H08-391D strain, and its converted colistin-resistant strain H08-391D-R produced relatively small amounts of LPS compared with those of H08-391 and H08-391R (Fig. [5](#Fig5){ref-type="fig"}). In whole cell lysate, both H08-391 and H08-391R had the strong bands visible between 30 and 35 kDa corresponding to LPS core oligosaccharide with O-antigen. However, this band was not produced by H08-391D and H08-391D-R (Fig. [5](#Fig5){ref-type="fig"}). The band that may represent LPS core with O-antigen appeared in LPS purified in H08-391 and H08-391R, but not in H08-391D or H08-391D-R, consistent with the result shown in whole cell lysate. These data show that there are clear difference in the structure or quantity of the LPS between colistin-susceptible and -dependent strains.Figure 5LPS profile of the strains H08-391, H08-391R, H08-391D, and H08-391D-R.

Differences in antimicrobial susceptibilities {#Sec9}
---------------------------------------------

To investigate the impact of lipid A modifications or deficiency on the antimicrobial susceptibilities of the mutant strains, we determined the MICs of selected antimicrobial agents for each strain. The colistin-susceptible WT strain, H08-391, was resistant to all antibiotics tested, except to polymyxins and tigecycline, while its colistin-resistant derivative, H08-391R, exhibited reduced susceptibility to polymyxins (MICs: 64--128 mg/L for colistin and 64 mg/L for polymyxin B, Table [3](#Tab3){ref-type="table"}). The colistin-dependent mutant, H08-391D, showed increased susceptibility to several antimicrobial agents, including carbapenems. However, it exhibited an extremely high colistin MIC (\>5120 mg/L). The converted colistin-resistant mutant, H08-391D-R, also showed increased susceptibility to most of the antibiotics tested. The colistin MIC (1280 mg/L) in H08-391D-R was also extremely high, despite being less than that of H08-391D (\>5120 mg/L). As the dependent strain and its converted resistant strain were highly increased susceptibility to several antimicrobial agents, they displayed increase in sensitivity to the other antibiotics, such as vacomycin and azithromycin which are used to treat Gram-positive pathogens. These results were confirmed consistently in the strains of H06-855 lineage.Table 3Antimicrobial susceptibilities of the strains in *A. baumannii* H08-391 and H06-855 lineages to selected antibiotics.**AntibioticAntimicrobial susceptibility (MIC, mg/L)** ^**a,b**^**H08-391H06-855WTRDD-RWTRDD-R**Colistin1 (S)**[64--128 (R)]{.ul}[\>5120 (R)]{.ul}[1280 (R)]{.ul}**[1 (S)]{.ul}**[64 (R)]{.ul}[\>5120 (R)]{.ul}[2560 (R)]{.ul}**Polymyxin B1 (S)**[64 (R)]{.ul}[\>64 (R)]{.ul}[\>64 (R)]{.ul}**[0.5 (S)]{.ul}**[64 (R)]{.ul}[\>64 (R)]{.ul}[\>64 (R)]{.ul}**Imipenem**[\>64 (R)]{.ul}[\>64 (R)]{.ul}**1 (S)1 (S)**16 (R)[16 (R)]{.ul}**0.25 (S)0.25 (S)Meropenem**[\>64 (R)]{.ul}[\>64 (R)]{.ul}**1 (S)0.5 (S)**16 (R)[8 (R)]{.ul}**0.125 (S)0.125 (S)Tigecycline2 (−)2 (−)0.125 (−)0.125 (−)4 (−)2 (−)0.25 (−)0.25 (−)Tetracycline**[\>64 (R)]{.ul}[\>64 (R)]{.ul}[16 (R)]{.ul}[16 (R)]{.ul}[16 (R)]{.ul}[16 (R)]{.ul}[16 (R)]{.ul}[16 (R)]{.ul}**Ciprofloxacin**[\>64 (R)]{.ul}[64 (R)]{.ul}[16 (R)]{.ul}[32 (R)]{.ul}[\>64 (R)]{.ul}[64 (R)]{.ul}[32 (R)]{.ul}[32 (R)]{.ul}**Amikacin**[128 (R)]{.ul}[128 (R)]{.ul}**16 (S)16 (S)**[\>128 (R)]{.ul}[128 (R)]{.ul}**2 (S)2 (S)Cefepime**[\>64 (R)]{.ul}[\>64 (R)]{.ul}**2 (S)4 (S)**[\>64 (R)]{.ul}[\>64 (R)]{.ul}**4 (S)4 (S)Ceftriaxone**[\>128 (R)]{.ul}[\>128 (R)]{.ul}**0.5 (S)1 (S)**[\>128 (R)]{.ul}[\>128 (R)]{.ul}**1 (S)1 (S)Ceftazidime**[\>64 (R)]{.ul}[64 (R)]{.ul}**1 (S)2 (S)**[\>64 (R)]{.ul}[64 (R)]{.ul}**8 (S)8 (S)Piperacillin/tazobactam**[\>256/4 (R)]{.ul}[\>256/4 (R)]{.ul}[128/4 (R)]{.ul}[128/4 (R)]{.ul}[\>256/4 (R)]{.ul}[\>256/4 (R)]{.ul}[256/4 (R)]{.ul}[256/4 (R)]{.ul}**Ampicillin/sulbactam**[64/32 (R)]{.ul}[32/16 (R)]{.ul}**2/1 (S)8/4 (S)**[\>64/32 (R)]{.ul}[32/16 (R)]{.ul}**4/2 (S)4/2 (S)Rifampin2 (−)1 (−)≤0.06 (−)≤0.06 (−)4 (−)2 (−)≤0.06 (−)≤0.06 (−)Azithromycin64 (−)64 (−)2 (−)2 (−)32 (−)32 (−)1 (−)2 (−)Vancomycin\>64 (−)\>64 (−)1 (−)1 (−)\>64 (−)\>64 (−)2 (−)4 (−)^a^S, sensitive; R, resistant; −, no breakpoint.^b^MIC values in bold and underline indicate resistance toward the antimicrobial agent.

Impact of membrane permeability on colistin dependence and resistance {#Sec10}
---------------------------------------------------------------------

To establish a link between membrane permeability and the structure of lipid A, which resides in the bacterial outer membrane and affects colistin susceptibility, we measured the membrane potential of the strains using the fluorescent membrane-potential indicator probe, 3,3′-diethyloxacarbocyanine iodide (DiOC~2~\[3\]). There were no significant differences in the red to green fluorescence intensity ratios between H08-391 and H08-391R, indicating that the lipid A modification by pEtN in H08-391R had little effect on its outer membrane permeability (Fig. [6](#Fig6){ref-type="fig"}). However, the fluorescence intensity ratios in H08-391D and H08-391D-R were almost half of those observed in H08-391 and H08-391R. These results imply that the defective lipid A structures found in H08-391D and H08-391D-R significantly affected their membrane permeability. Upon cotreatment of the bacteria with DiOC~2~(3) and a proton ionophore, carbonyl cyanide 3-chlorophenylhydrazone (CCCP), the membrane potential decreased in all strains, indicating that the proton gradient was uniformly destroyed.Figure 6Comparison of the membrane potential in the strains H08-391, H08-391R, H08-391D, and H08-391D-R. Error bars represent the standard deviation of three biological repeats, each performed in duplicate. Statistically significant differences in membrane potential between the strains were analyzed using Student's unpaired *t*-test using GraphPad Prism 5.

Discussion {#Sec11}
==========

Several studies, including a recent study from our lab, have described the phenomenon of colistin dependence in *A. baumannii* ^[@CR14]--[@CR16]^. We reported that a substantial proportion (approximately one-third) of colistin-susceptible isolates developed colistin dependence after exposure to colistin^[@CR16]^. Moreover, patients with *A. baumannii* bloodstream isolates that developed colistin dependence showed higher colistin-treatment failure than those without colistin-dependent isolates, although this result was not statistically significant. In this study, we demonstrated that colistin dependence develops into colistin resistance in the absence of antibiotic selection pressure.

The strain H08-391D showed the colistin-dependent phenotype, growing on agar plates only in the regions near the colistin disc. However, it exhibited a colistin MIC of \>64 mg/L, as determined by the broth microdilution method, and this fell within the colistin-resistance range (\>4 mg/L)^[@CR17]^. H08-391D exhibited constant growth even at an extremely high colistin concentration of 5120 mg/L. However, this colistin-dependent phenotype was probably unstable, as it converted into the colistin-resistant phenotype after only the fourth serial passage in medium lacking colistin. The preservation of the IS*Aba1* insertion in *lpxC* or amino acid substitution of colistin-dependent mutants in their converted colistin-resistant mutants may indicate that the colistin resistance phenotype was derived from the colistin-dependent strains. Because the colistin-dependent strain lacks LPS, it could not be reversed into colistin susceptibility even on the media without colistin. Development of colistin resistance from colistin dependence may be a common phenomenon in *A. baumannii*, as it was exhibited by two other strains as well: H06-855D and H09-146D. These colistin-resistant mutants derived from the colistin-dependent mutants showed high-level resistance to colistin (MIC: 1280 mg/L). Further, their colistin-resistant phenotype was preserved for up to 20 serial transfers in the absence of selective pressure. This indicates that these mutants may be similar to the colistin-resistant mutant derived from the colistin-susceptible WT strain in terms of stability.

In gram-negative bacteria, including *A. baumannii*, colistin resistance has evolved owing to modifications in lipid A, which results in a decrease in the net charge of the outer membrane^[@CR8],[@CR9]^. In addition, the loss of LPS owing to mutations or disruption of genes involved in lipid A biosynthesis, such as *lpxA*, *lpxD*, and *lpxC*, has been reported as responsible for colistin resistance in *A. baumannii* ^[@CR12],[@CR13]^. In our study, colistin resistance in *A. baumannii* was attributed to the addition of pEtN to lipid A. The colistin-resistant mutant derived from the WT strain exhibited several amino acid alterations in the *pmrCAB* operon, but not in the *lpxACD* operon. On the contrary, both the colistin-dependent mutant and its colistin-resistant derivative had a disruption (IS*Aba1* insertion) in the *lpxC* gene, which encodes the UDP-3-O-acyl-N-acetylglucosamine deacetylase and plays an essential role in the biosynthesis of lipid A^[@CR18]^. Further, the *pmrCAB*, *lpxA*, and *lpxC* genes were overexpressed in the colistin-resistant strain (H08-391R) derived from the WT strain, but not in the colistin-dependent strain and its derivative resistant strain. Additionally, MALDI-TOF MS analysis showed that both the colistin-dependent mutant and its colistin-resistant derivative lacked major peaks (*m*/*z* 1728 and *m*/*z* 1910) characteristic of lipid A, which were present in the spectra of lipid A from the colistin-susceptible WT strain and the colistin-resistant mutant derived *in vitro*. Although some peaks corresponding to lipid A were found in MS analysis of colistin-dependent strain, they may be remnants of lipid A during conversion into colistin dependence. Thus, we postulate that disruption in *lpxC* probably results in the loss of LPS or defects in its structure, which have an impact on the emergence of colistin dependence. Such LPS loss or structural defects would be preserved in the colistin-resistant mutant derived from the colistin-dependent mutant. However, the mechanisms that contribute to the survival of LPS-deficient *A. baumannii* and protection of the cell from colistin stress are unknown.

Although H08-391D and H08-391D-R had extremely high colistin MICs, they showed decreased MICs for most other antibiotics tested, except polymyxins. This is in concordance with previous studies with colistin-dependent *Acinetobacter* sp.^[@CR14],[@CR15]^, but our findings that the colistin-resistant strain derived from the colistin-dependent mutant showed similar antibiotic susceptibilities as the latter is novel. It is well known that the bacterial outer membrane acts as a selective permeability barrier between the cytoplasm and the outside environment^[@CR19],[@CR20]^. The outer membrane fragility in colistin-dependent *A. baumannii* may have contributed to its increased susceptibility to other antibiotics. In addition, the increased susceptibility to other antibiotics in the colistin-dependent mutant and its colistin-resistant derivative may provide new insights for the development of clinical therapeutics against *A. baumannii* infections.

In conclusion, our work reveals that colistin dependence in *A. baumannii* may be a transient phenotype, and might convert to an extremely resistant phenotype even when cultured in the antibiotic-free media. The colistin-dependent phenotype may arise from the loss of LPS or defects in its structure, resulting from the disruption of LpxC. However, we do not yet understand the comprehensive mechanisms of colistin dependence and its clinical implications. Thus, further investigations of the genetic basis of colistin dependence in *A. baumannii* are required.

Materials and Methods {#Sec12}
=====================

Bacterial strains and growth conditions {#Sec13}
---------------------------------------

Two colistin-susceptible *A. baumannii* strains, H08-391and H06-855, isolated from patients with bacteremia were used as the parental strains. Colistin-resistant subpopulations and colistin-dependent mutants were obtained from H08-391 and H06-855 through population analysis and colistin disc diffusion assay^[@CR16]^. We then obtained the colistin-resistant mutants H08-391D-R and H06-855D-R from H08-391D and H06-855D, respectively, by serial passaging in drug-free medium. Briefly, we picked three or four colistin-dependent colonies surviving near the colistin disc, and cultured them overnight. Overnight cultures of the dependent mutants were diluted into fresh LB medium (1:100) without colistin, and incubated with vigorous shaking at 37 °C for 24 h. The MICs of colistin were estimated using the broth microdilution method during the course of each passage, for all serial transfer cultures and colistin disc diffusion assay were performed. Bacteria were routinely grown in the CA-MH media, with or without 10 mg/L colistin, at 37 °C.

Determination of antimicrobial susceptibility {#Sec14}
---------------------------------------------

The MICs of 16 antimicrobial agents, including colistin, polymyxin B, imipenem, meropenem, tigecycline, tetracycline, ciprofloxacin, amikacin, cefepime, ceftriaxone, ceftazidime, piperacillin/tazobactam, ampicillin/sulbactam, rifampin, azithromycin, and vancomycin were evaluated using the standard broth microdilution method according to the CLSI guidelines M100-S25^[@CR17]^. For the colistin-dependent mutants, H08-391D and H06-855D, colistin MICs were determined using concentrations ranging from 5 to 5120 mg/L. The MIC was defined as the lowest antibiotic concentration that yielded no visible growth. *Escherichia coli* ATCC 25922 and *Pseudomonas aeruginosa* ATCC 27853 were employed as control strains. The MIC values were confirmed by three independent experiments. To verify colistin resistance and dependence, the colistin disc diffusion assay was performed as previously described^[@CR21]^.

Sequencing of *pmrCAB*, *lpxC*, *lpxA*, and *lpxD* genes {#Sec15}
--------------------------------------------------------

The *pmrCAB*, *lpxC*, *lpxA*, and *lpxD* gene sequences (ACICU_03004, ACICU_03003, ACICU_03002, ACICU_03528, ACICU_02088, and ACICU_02090 in *A. baumannii* ACICU, respectively) were determined using the primers listed in Table [4](#Tab4){ref-type="table"}. The sequences were analyzed using the DNASTAR software (DNASTAR Inc., Madison, WI, USA). The amino acid sequences of the WT strain, H08-391, and its derivatives were compared with those of the reference strain, *A. baumannii* ACICU (GenBank accession number: CP000863).Table 4Oligonucleotides used in this study.**PrimerSequence (5′ → 3′)Amplicon size (bp)ReferencePrimers for sequencing**pmrC-FCGGTAAGCGTGATACCTTTGA1966This studypmrC-IFCCGTGGTCGGTGTTTTACTTpmrC-RGAGCCAAACCATCTAAACCGTpmrA-FACTGGACATGTTGCACTCTT852This studypmrA-RTGAAGTGCAACCTTATAAGCACpmrB-FATTCGAACCATCCGAGGACT1504This studypmrB-RTGCGAGGAGCACATTTTCTAlpxA-FTGAAGCATTAGCTCAAGTTT1179(12)lpxA-RGTCAGCAAATCAATACAAGAlpxD-FCAAAGTATGAATACAACTTTTGAG1483(12)lpxD-RTTGAGCTAATGCTTCAACAAlpxC-FTGAAGATGATGTTCCTGCAA1504(12)lpxC-RTGGTGAAAATCAGGCAATGAA**Primers for qRT-PCR**rpoB-QFATGCCGCCTGAAAAAGTAAC154(22)rpoB-QRTCCGCACGTAAAGTAGGAACpmrC-QFTGGAAATGGACTGCCAAAAT137This studypmrC-QRACTTCCGAAACATCGGTCTGlpxA-QFGTGGGGCTTCTTTGATCCTT139This studylpxA-QRCCAACCTTTTCTTCGCATACClpxC-QFGTGAGGCACGAACTTTTGGT107This studylpxC-QRTCGGCAAATCGTAATCCTTC

Quantitative RT-PCR (qRT-PCR) {#Sec16}
-----------------------------

Expression levels of the *pmrCAB* operon, *lpxA*, *lpxD*, and *lpxC* were determined by qRT-PCR. Total RNA was extracted from mid-log phase bacterial cultures (optical density at 600 nm \[OD~600~\]: \~0.5) using the Qiagen RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Contaminating genomic DNA was removed from the RNA samples using the Ambion DNA-free kit (Invitrogen, Carlsbad, CA, USA), in accordance with the manufacturer's protocol. Purified RNA was quantified spectrophotometrically. Reverse transcription reactions were performed using the Omniscript Reverse Transcriptase (Qiagen), per manufacturer's protocol. To quantify the target genes, qRT-PCR was performed using the SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) on the QuantStudio 6 Flex Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). The primers for this study were designed using Primer 3 (Table [4](#Tab4){ref-type="table"}). The fold-changes were calculated according to the threshold cycle (CT) method, using the *rpoB* gene, which encodes the β subunit of bacterial RNA polymerase, as the reference^[@CR22]^. The experiments were repeated with three independent cultures, each tested in duplicate. Differences in the expression levels of the target genes were analyzed by Student's unpaired *t*-test using GraphPad Prism 5. Differences were considered to be significant at P \< 0.05.

Transcriptomic analysis (mRNA sequencing) {#Sec17}
-----------------------------------------

Overnight culture of *A. baumannii* H08-391, H08-391D, H06-855 and H06-855D was diluted into fresh LB broth (1:100) and then the culture was incubated with vigorous shaking (250 rpm) at 37 °C until the OD600 reaches 0.5-0.6. Total RNA extracted using the Qiagen RNeasy Mini Kit (Qiagen, Hilden, Germany). After isolation of RNA, cDNA was synthesized and sequencing libraries were generated in strand-specific manner according to the Illumine standard protocol for high-throughput sequencing. Library sequencing was performed with Illumina HiSeq. 2000 sequencing system (Illumina, USA) at Macrogen Inc. (Seoul, Korea). Raw reads were mapped to the reference genome sequence of *A. baumannii* ACICU (GenBank accession No. CP000863.1). Expression levels of mRNA were expressed as reads per kilobase per million sequence reads (RPKM), which considers the effect of sequencing depth and gene length for the reads.

Lipid A isolation and structural analysis {#Sec18}
-----------------------------------------

For structural analysis, lipid A was extracted by an ammonium hydroxide-isobutyric acid method as previously described^[@CR23]^, and subjected to MALDI-TOF MS analysis. Briefly, freshly washed cells (10 mg) were suspended in 400 μL of isobutyric acid-1M ammonium hydroxide mixture (5:3, vol/vol), and incubated for 2 h at 100 °C in a screw-cap test tube, with occasional vortexing. The mixture was then cooled on ice and centrifuged at 8000 g for 15 min. The supernatant was transferred to a new tube, mixed with an equal volume of water, and lyophilized overnight at −70 °C. The lyophilized sample was then washed twice with 400 μL of methanol, and centrifuged at 5000 rpm for 15 min. Finally, the insoluble lipid A was solubilized in 100 μL chloroform-methanol-water mixture (3:1.5:0.25, v/v/v). The lipid A structure was analyzed using MALDI-TOF mass spectrometry in the negative-ion mode^[@CR8],[@CR24]^. All MALDI-TOF analyses were performed on a Bruker Ultraflex III TOF/TOF mass spectrometer (Bruker Daltonics, Coventry, UK) using the FlexControl 3.0 acquisition software. The matrix used for lipid A analysis was 2,5-dihydroxybenzoic acid (DHB; Sigma Chemical Co., St. Louis, MO, USA). The DHB solution (10 mg/mL) was prepared using a mixture of water and acetonitrile (1:4, vol/vol). All lipid A samples were premixed with the DHB solution (1:1, vol/vol) before MALDI measurements, and 1 μL of the resulting mixture was spotted on the MALDI metallic target. Lipid A from *E. coli* F583 was used as an external standard and mass calibrant.

Extraction and visualization of LPS {#Sec19}
-----------------------------------

For the LPS extraction, we used a hot aqueous-phenol method as previously described with some modifications^[@CR25]^. In brief, 1.5 ml bacterial suspensions (OD600 of 0.5) were centrifuged and the pellets were resuspended in 200 μL SDS-lysis buffer (2% β-mercaptoethanol, 2% SDS and 10% glycerol in 50 mM Tris-HCL, pH 6.8) and boiled for 15 minutes. In order to eliminate contaminating protein and nucleic acids, proteinase K, DNase and RNase was subsequently treated. Then, an equal volume of ice-cold Tris-saturated phenol was added and the mixtures were incubated at 65 °C for 15 minutes with vortexing occasionally. At the next step, 1 mL of diethyl ether were added to the mixtures and centrifuged at 20000 × *g* for 10 minutes. The bottom layer was extracted and the final purified LPS product was separated by SDS-PAGE. Silver staining of the gels was performed according to the standard protocol.

Membrane potential assay {#Sec20}
------------------------

Membrane potential was measured using the BacLight Bacterial Membrane Potential Kit (Molecular Probes, Invitrogen, Carlsbad, CA, USA) and the xMark Microplate Absorbance Spectrophotometer (Bio-Rad, Irvine, CA, USA) according to the manufacturer's protocol. In brief, overnight cultures were diluted 1:100 in fresh LB medium and grown to the exponential phase (OD~600~: 0.5). The bacterial cultures were diluted to approximately 1 × 10^6^ cells/mL in filtered phosphate-buffered saline (PBS). Three aliquots of 1 mL each of the bacterial suspension were prepared for the test sample, depolarized control, and unstained control. To the depolarized control sample, 10 μL of 500 μM CCCP was added. Then, 10 μL of 3 mM DiOC~2~(3) was added to all tubes except that of the unstained control, and incubated for 10 min at 24 °C. The ratio of the red (Ex. 530 nm/Em. 590 nm) and green (Ex. 485 nm/Em. 528 nm) fluorescence intensities was used as an indicator of the membrane potential. Data were analyzed using the Microplate Manager Software 6.0. The experiments were repeated with three independent cultures, each tested in triplicate.
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